Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 0.0 | BCD100624C002 | 19.3 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 0.5 | BCD100624C005 | 15.5 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 1.0 | BCD100624C009 | 17.6 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 2.0 | BCD100624C013 | 14.7 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 4.0 | BCD100624C017 | 22.4 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 8.0 | BCD100624C021 | 13.5 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 12.0 | BCD100624C025 | 21 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 24.0 | BCD100624C029 | 22.4 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 0.0 | BCD100624C001 | 28.8 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 0.5 | BCD100624C003 | 10.5 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 1.0 | BCD100624C007 | 26 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 2.0 | BCD100624C011 | 16.8 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 4.0 | BCD100624C015 | 15.2 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 8.0 | BCD100624C019 | 12.3 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 12.0 | BCD100624C023 | 15.2 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 24.0 | BCD100624C027 | 17.4 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100624C006 | 15.3 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100624C010 | 18 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100624C014 | 17.7 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100624C018 | 21.3 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100624C022 | 18.4 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100624C026 | 19.5 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100624C030 | 33.5 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 0.5 | BCD100624C004 | 18.2 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 1.0 | BCD100624C008 | 17.3 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 2.0 | BCD100624C012 | 16 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 4.0 | BCD100624C016 | 22.4 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 8.0 | BCD100624C020 | 25.5 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 12.0 | BCD100624C024 | 39 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 24.0 | BCD100624C028 | 21.1 | pmol/sample |